Research by Topic: Risperidone

Is Medication Information for Children with Autism Spectrum Disorder Monitored and Coordinated Across Professionals? Findings from a Teacher Survey

Published March 1, 2013 in School Mental Health

This study examined school-based medication monitoring in children with ASD. Researchers found that less than half of teachers of medicated students were aware that students were taking medication and no teachers were communicating with prescribing physicians about student behavior and side effects. Since monitoring medication across settings helps physicians assess drug safety and effectiveness, the authors argue for increased communication among professionals.

Filed under: , , , , , ,

Meta-Analysis of The Effects of Risperidone or Aripiprazole on Individuals with ASD

Published January 1, 2013 in Research in Autism Spectrum Disorders

This study analyzes the efficacy and secondary effects of the drugs, Risperidone and Aripipazole.

Filed under: , , ,

Treatments Show Promise in Reducing Autism-related Behaviors, but Some have Significant Side Effects

Published April 4, 2011 in Agency for Heathcare Research and Quality

Some medical and behavioral treatments show promise for reducing certain behaviors in children with autism spectrum disorders (ASDs), but more research is needed to assess the potential benefits and harms, according to a new report funded by HHS’ Agency for Healthcare Research and Quality (AHRQ). The research results were published online in the journal Pediatrics.

Filed under: , , ,

A Systematic Review of Medical Treatments for Children with Autism Spectrum Disorders

Published April 1, 2011 in Pediatrics, McPheeters et al.

Researchers at Vanderbilt University reviewed evidence regarding medical treatment of children 12 years old and younger with an Autism Spectrum Disorder (ASD). It was found that risperidone and aripiprazole for treatment of challenging and repetitive behaviors in children with ASDs. However, there are significant adverse effects of these medicines, including severe impairment or risk of […]

American Academy of Pediatrics

Filed under: , , , , ,

Moderators, Mediators,and Other Predictors of Risperidone Response in Children with Autistic Disorder and Irritability

Published April 1, 2010 in Journal of Childhood and Adolescent Psychopharmacology, Arnold et al

The National Institute of Mental Health (NIMH) Research Units on Pediatric Psychopharmacology (RUPP) Autism Network found an effect size of d = 1.2 in favor of risperidone on the main outcome measure in an 8-week double-blind, placebo-controlled trial for irritability in autistic disorder. This paper explores moderators and mediators of this effect. This study found […]

Filed under: , , ,